Mayo Clinic researchers identify therapy that shrinks tumors in patients with myelomaMyeloma13 March 2017
Delays in access to new cancer medicines and unjustifiable price rises for old ones disadvantage patients unnecessarilyAccess28 January 2017
Patients and cancer experts launch a joint vision for improving cancer outcomes in EuropeMyeloma, Patient evidence12 January 2017
Innovative Medicines Initiative (IMI) approves € 40 million project for better care of patients with haematologic malignanciesMyeloma9 January 2017
Addition of daratumumab to bortezomib and dexamethasone in patients with relapsed or refractory shows promising results in a phase III trialMyeloma13 October 2016
SURVEY: Reasonable agreements between pharmaceutical companies and patient advocatesMPE6 October 2016
EMA reconsiders and gives its positive opinion for the approval of ixazomibAccess, Myeloma17 September 2016
